Defining ‘Signal’ and its Subtypes in Pharmacovigilance Based on a Systematic Review of Previous Definitions
- 1 January 2009
- journal article
- review article
- Published by Springer Nature in Drug Safety
- Vol. 32 (2) , 99-110
- https://doi.org/10.2165/00002018-200932020-00003
Abstract
Having surveyed the etymology and previous definitions of the pharmacovigilanceterm ‘signal’, we propose a definition that embraces all the surveyed ideas, reflects real-world pharmacovigilance...Keywords
This publication has 18 references indexed in Scilit:
- The application of knowledge discovery in databases to post‐marketing drug safety: example of the WHO databaseFundamental & Clinical Pharmacology, 2008
- Should we tolerate tolerability as an objective in early drug development?British Journal of Clinical Pharmacology, 2007
- The NSAID roller coaster: more about rofecoxibBritish Journal of Clinical Pharmacology, 2006
- Communication of findings in pharmacovigilance: use of the term “signal” and the need for precision in its useEuropean Journal of Clinical Pharmacology, 2005
- Clarification of Terminology in Drug SafetyDrug Safety, 2005
- Safety Related Drug-Labelling ChangesDrug Safety, 2004
- Use of a spontaneous adverse drug events database for identification of unanticipated drug benefitsClinical Pharmacology & Therapeutics, 2002
- The New Zealand intensive medicines monitoring programme in pro-active safety surveillancePharmacoepidemiology and Drug Safety, 2000
- Acetaminophen and Other Risk Factors for Excessive Warfarin AnticoagulationJAMA, 1998
- Principles of Signal Detection in PharmacovigilanceDrug Safety, 1997